Seneca Growth Capital VCT PLC Total Assets

Latest as of December 2024: GBX14.16 Million GBX ≈ $1.72K USD

Seneca Growth Capital VCT PLC total assets. Based on the latest financial reports, Seneca Growth Capital VCT PLC (HYG) holds total assets worth GBX14.16 Million GBX (≈ $1.72K USD) as of December 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see HYG market cap for the company's overall valuation and market capitalisation.

Total Assets of Seneca Growth Capital VCT PLC (2001–2024)

Total assets of Seneca Growth Capital VCT PLC from 2001 to 2024. This chart illustrates how Seneca Growth Capital VCT PLC's total assets have evolved over time, based on quarterly financial data. See Seneca Growth Capital VCT PLC stock quote for real-time trading data and today's change.

Seneca Growth Capital VCT PLC - Asset Composition Analysis

Seneca Growth Capital VCT PLC Total Assets Breakdown (December 2024)

Seneca Growth Capital VCT PLC total assets breakdown as of December 2024. Seneca Growth Capital VCT PLC's total assets of GBX14.16 Million consist of 10.9% current assets and 89.1% non-current assets.

Asset Category Amount (GBX) % of Total Assets
Cash & Equivalents GBX0.00 10.9%
Accounts Receivable GBX11.00K 0.1%
Inventory GBX0.00 0.0%
Property, Plant & Equipment GBX0.00 0.0%
Intangible Assets GBX0.00 0.0%
Goodwill GBX0.00 0.0%

Asset Composition Trend (2001–2024)

This chart illustrates how Seneca Growth Capital VCT PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Seneca Growth Capital VCT PLC current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Seneca Growth Capital VCT PLC's current assets represent 10.9% of total assets in 2024, an increase from 0.0% in 2001.
  • Cash Position: Cash and equivalents constituted 10.9% of total assets in 2024, up from 0.0% in 2001.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2001.
  • Asset Diversification: The largest asset category is accounts receivable at 0.1% of total assets.

Seneca Growth Capital VCT PLC Competitors by Total Assets

Key competitors of Seneca Growth Capital VCT PLC based on total assets are shown below.

Company Country Total Assets
Strive, Inc.
NASDAQ:ASST
USA $1.38 Billion
RiverNorth Managed Duration Municipal Income Fund II Inc.
NYSE:RMMZ
USA $229.86 Million
Brookfield Corporation
TO:BN
Canada CA$518.03 Billion
Groep Brussel Lambert NV
BR:GBLB
Belgium €25.06 Billion
Sprott Physical Gold Trust
TO:PHYS
Canada CA$14.74 Billion
REINET INVESTMENTS S.C.A.
F:RNT
Germany €6.92 Billion
CI Financial Corp
TO:CIX
Canada CA$11.01 Billion
Shaanxi International Trust Co Ltd
SHE:000563
China CN¥25.61 Billion

Seneca Growth Capital VCT PLC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 9.55 7.70 16.58
Quick Ratio 9.55 7.77 0.01
Cash Ratio 0.00 0.00 0.00
Working Capital GBX1.38 Million GBX1.27 Million GBX3.68 Million

Seneca Growth Capital VCT PLC - Advanced Valuation Insights

This section examines the relationship between Seneca Growth Capital VCT PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.13
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) -17.8%
Total Assets GBX14.16 Million
Market Capitalization $4.94K USD

Valuation Analysis

Below Book Valuation: The market values Seneca Growth Capital VCT PLC's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Seneca Growth Capital VCT PLC's assets decreased by 17.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Seneca Growth Capital VCT PLC (2001–2024)

The table below shows the annual total assets of Seneca Growth Capital VCT PLC from 2001 to 2024.

Year Total Assets Change
2024-12-31 GBX14.16 Million
≈ $1.72K
-17.82%
2023-12-31 GBX17.23 Million
≈ $2.10K
-7.63%
2022-12-31 GBX18.65 Million
≈ $2.27K
+2.04%
2021-12-31 GBX18.28 Million
≈ $2.22K
+63.41%
2020-12-31 GBX11.19 Million
≈ $1.36K
+28.97%
2019-12-31 GBX8.67 Million
≈ $1.06K
-11.16%
2018-12-31 GBX9.76 Million
≈ $1.19K
+75.23%
2017-12-31 GBX5.57 Million
≈ $677.83
-7.80%
2016-12-31 GBX6.04 Million
≈ $735.14
-8.32%
2015-12-31 GBX6.59 Million
≈ $801.81
-18.60%
2014-12-31 GBX8.10 Million
≈ $985.05
-7.03%
2013-12-31 GBX8.71 Million
≈ $1.06K
-19.59%
2012-12-31 GBX10.83 Million
≈ $1.32K
+87.91%
2011-12-31 GBX5.76 Million
≈ $701.19
-8.70%
2010-12-31 GBX6.31 Million
≈ $767.99
-14.98%
2009-12-31 GBX7.42 Million
≈ $903.29
+42.19%
2008-12-31 GBX5.22 Million
≈ $635.24
+12.69%
2007-12-31 GBX4.63 Million
≈ $563.70
+7.07%
2006-12-31 GBX4.33 Million
≈ $526.47
-25.52%
2005-12-31 GBX5.81 Million
≈ $706.91
-8.29%
2004-12-31 GBX6.33 Million
≈ $770.79
-10.50%
2003-12-31 GBX7.08 Million
≈ $861.19
+3.89%
2002-12-31 GBX6.81 Million
≈ $828.95
+13526.00%
2001-12-31 GBX50.00K
≈ $6.08
--

About Seneca Growth Capital VCT PLC

LSE:HYG UK Asset Management
Market Cap
$4.94K
GBX40.58 Million GBX
Market Cap Rank
#31924 Global
#1314 in UK
Share Price
GBX5.00
Change (1 day)
+0.00%
52-Week Range
GBX0.06 - GBX9.00
All Time High
GBX33.12
About

Seneca Growth Capital VCT plc is a venture capital trust specializes in growth capital. It invests in emerging biotechnology companies. It prefers to invest in unquoted and quoted MedTech companies. The fund seeks to invest in the United Kingdom, IIe-de-France, Burgundy, France, European Developed Markets. It typically invests in companies with sales greater than £10 million ($11.90 million), gro… Read more